|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 9/12 | (2006.01) |
| A61P 9/12 | (2018.01) | ||
| A61K 31/505 | (2006.01) | ||
| A61K 31/4184 | (2013.01) | ||
| A61K 31/4184 | (2006.01) | ||
| A61K 9/2009 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/505 | (2013.01) | ||
| A61K 9/2077 | (2013.01) |
| (11) | Patento numeris | 3090744 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14876904.5 |
| Europos patento paraiškos padavimo data | 2014-12-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-11-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-11-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/KR2014/012677 |
| Data | 2014-12-23 |
| (87) | Numeris | WO 2015/102282 |
| Data | 2015-07-09 |
| (30) | Numeris | Data | Šalis |
| 20130167406 | 2013-12-30 | KR |
| (72) |
LEE, Jae Won , KR
PARK, Cheol Won , KR
JUN, Hun , KR
LEE, Tae Won , KR
KIM, Nam Hyuck , KR
LEE, Sun Young , KR
YU, Ji Hyuck , KR
|
| (73) |
Alvogen Korea Co., Ltd. ,
13 Fl., 10, Gukjegeumyung-ro
Yeongdeungpo-gu, Seoul 07326,
KR
|
| (54) | PHARMACEUTICAL COMPLEX FORMULATION COMPRISING ANGIOTENSIN II RECEPTOR BLOCKER AND HMG-COA REDUCTASE INHIBITOR |
| PHARMACEUTICAL COMPLEX FORMULATION COMPRISING ANGIOTENSIN II RECEPTOR BLOCKER AND HMG-COA REDUCTASE INHIBITOR |